Isoray, Inc. (ISR)

$0.433

+0.03 (+6.44%)
Rating:
Recommendation:
Buy
Symbol ISR
Price $0.433
Beta 0.925
Volume Avg. 0.26M
Market Cap 61.503M
Shares () -
52 Week Range 0.25-0.75
1y Target Est -
DCF Unlevered ISR DCF ->
DCF Levered ISR LDCF ->
ROE -7.13% Neutral
ROA -7.03% Neutral
Operating Margin -
Debt / Equity 4.61% Neutral
P/E -
P/B 0.97 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ISR news


Ms. Lori Woods
Healthcare
Medical Devices
American Stock Exchange

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.